199 related articles for article (PubMed ID: 27121063)
21. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer.
Wang Y; Wang J; Zhong J; Deng Y; Xi Q; He S; Yang S; Jiang L; Huang M; Tang C; Liu R
Med Oncol; 2015 Jan; 32(1):379. PubMed ID: 25429837
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin-specific peptidase 14 maintains estrogen receptor α stability via its deubiquitination activity in endometrial cancer.
Su Y; Zeng K; Liu S; Wu Y; Wang C; Wang S; Lin L; Zou R; Sun G; Luan R; Zhou B; Bai Y; Niu J; Zhang Y; Zhao Y
J Biol Chem; 2023 Jan; 299(1):102734. PubMed ID: 36423684
[TBL] [Abstract][Full Text] [Related]
24. USP14 inhibition regulates tumorigenesis by inducing apoptosis in gastric cancer.
Lee MY; Kim MJ; Jin JO; Lee PC
BMB Rep; 2023 Aug; 56(8):451-456. PubMed ID: 37401238
[TBL] [Abstract][Full Text] [Related]
25. Small Foci of Serous Component as a Predictor of Recurrence and Prognosis for Stage IA Endometrial Carcinomas.
Miyamoto M; Takano M; Tsuda H; Soyama H; Aoyama T; Ishibashi H; Kato K; Iwahashi H; Matuura H; Yoshikawa T; Suzuki A; Hirata J; Furuya K
Oncology; 2017; 93(1):29-35. PubMed ID: 28259868
[TBL] [Abstract][Full Text] [Related]
26. Emerging role of ubiquitin-specific protease 14 in oncogenesis and development of tumor: Therapeutic implication.
Liu B; Chen J; Zhang S
Life Sci; 2019 Dec; 239():116875. PubMed ID: 31676235
[TBL] [Abstract][Full Text] [Related]
27. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
[TBL] [Abstract][Full Text] [Related]
28. USP14 Inhibition Regulates Tumorigenesis by Inducing Autophagy in Lung Cancer In Vitro.
Han KH; Kwak M; Lee TH; Park MS; Jeong IH; Kim MJ; Jin JO; Lee PC
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653087
[TBL] [Abstract][Full Text] [Related]
29. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Alonso-Alconada L; Santacana M; Garcia-Sanz P; Muinelo-Romay L; Colas E; Mirantes C; Monge M; Cueva J; Oliva E; Soslow RA; Lopez MA; Palacios J; Prat J; Valls J; Krakstad C; Salvesen H; Gil-Moreno A; Lopez-Lopez R; Dolcet X; Moreno-Bueno G; Reventos J; Matias-Guiu X; Abal M
Int J Cancer; 2015 Apr; 136(8):1863-73. PubMed ID: 25219463
[TBL] [Abstract][Full Text] [Related]
30. Proteasome-associated cysteine deubiquitinases are molecular targets of environmental optical brightener compounds.
Castro I; Ekinci E; Huang X; Cheaito HA; Ahn YH; Olivero-Verbel J; Dou QP
J Cell Biochem; 2019 Aug; 120(8):14065-14075. PubMed ID: 30963630
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of ubiquitin-specific protease 14 (USP14) inhibits breast cancer cell proliferation and metastasis, but promotes apoptosis.
Zhu L; Yang S; He S; Qiang F; Cai J; Liu R; Gu C; Guo Z; Wang C; Zhang W; Zhang C; Wang Y
J Mol Histol; 2016 Feb; 47(1):69-80. PubMed ID: 26712154
[TBL] [Abstract][Full Text] [Related]
32. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
[TBL] [Abstract][Full Text] [Related]
33. Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer.
Hashiguchi Y; Kasai M; Fukuda T; Ichimura T; Yasui T; Sumi T
Pathol Oncol Res; 2016 Jul; 22(3):501-4. PubMed ID: 26678075
[TBL] [Abstract][Full Text] [Related]
34. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
35. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
[TBL] [Abstract][Full Text] [Related]
36. Expression of ERCC1, p53, and class III β-tubulin do not reveal chemoresistance in endometrial cancer: results from an immunohistochemical study.
Vandenput I; Capoen A; Coenegrachts L; Verbist G; Moerman P; Vergote I; Amant F
Int J Gynecol Cancer; 2011 Aug; 21(6):1071-7. PubMed ID: 21792013
[TBL] [Abstract][Full Text] [Related]
37. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
[TBL] [Abstract][Full Text] [Related]
38. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.
Devis L; Moiola CP; Masia N; Martinez-Garcia E; Santacana M; Stirbat TV; Brochard-Wyart F; García Á; Alameda F; Cabrera S; Palacios J; Moreno-Bueno G; Abal M; Thomas W; Dufour S; Matias-Guiu X; Santamaria A; Reventos J; Gil-Moreno A; Colas E
J Pathol; 2017 Mar; 241(4):475-487. PubMed ID: 27873306
[TBL] [Abstract][Full Text] [Related]
39. USP14 activation promotes tumor progression in hepatocellular carcinoma.
Huang G; Li L; Zhou W
Oncol Rep; 2015 Dec; 34(6):2917-24. PubMed ID: 26397990
[TBL] [Abstract][Full Text] [Related]
40. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]